{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35264719",
  "DateCompleted": {
    "Year": "2022",
    "Month": "03",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "03",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "4150",
      "10.1038/s41598-022-08104-4"
    ],
    "Journal": {
      "ISSN": "2045-2322",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "1",
        "PubDate": {
          "Year": "2022",
          "Month": "Mar",
          "Day": "09"
        }
      },
      "Title": "Scientific reports",
      "ISOAbbreviation": "Sci Rep"
    },
    "ArticleTitle": "Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice.",
    "Pagination": {
      "StartPage": "4150",
      "MedlinePgn": "4150"
    },
    "Abstract": {
      "AbstractText": [
        "Models of animals that are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can usefully evaluate the efficacy of vaccines and therapeutics. In this study, we demonstrate that infection with the SARS-CoV-2 B.1.351 variant (TY8-612 strain) induces bodyweight loss and inflammatory cytokine/chemokine production in wild-type laboratory mice (BALB/c and C57BL/6\u00a0J mice). Furthermore, compared to their counterparts, BALB/c mice had a higher viral load in their lungs and worse symptoms. Importantly, infecting aged BALB/c mice (older than 6\u00a0months) with the TY8-612 strain elicited a massive and sustained production of multiple pro-inflammatory cytokines/chemokines and led to universal mortality. These results indicated that the SARS-CoV-2 B.1.351 variant-infected mice exhibited symptoms ranging from mild to fatal depending on their strain and age. Our data provide insights into the pathogenesis of SARS-CoV-2 and may be useful in developing prophylactics and therapeutics."
      ],
      "CopyrightInformation": "\u00a9 2022. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. yasui-fm@igakuken.or.jp."
          }
        ],
        "LastName": "Yasui",
        "ForeName": "Fumihiko",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan."
          }
        ],
        "LastName": "Matsumoto",
        "ForeName": "Yusuke",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan."
          }
        ],
        "LastName": "Yamamoto",
        "ForeName": "Naoki",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan."
          }
        ],
        "LastName": "Sanada",
        "ForeName": "Takahiro",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan."
          }
        ],
        "LastName": "Honda",
        "ForeName": "Tomoko",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan."
          }
        ],
        "LastName": "Munakata",
        "ForeName": "Tsubasa",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan."
          }
        ],
        "LastName": "Itoh",
        "ForeName": "Yasushi",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan."
          }
        ],
        "LastName": "Kohara",
        "ForeName": "Michinori",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "20nk0101615h0001",
        "Agency": "Japan Agency for Medical Research and Development",
        "Country": ""
      },
      {
        "GrantID": "20nk0101615h0001",
        "Agency": "Japan Agency for Medical Research and Development",
        "Country": ""
      },
      {
        "GrantID": "20nk0101615h0001",
        "Agency": "Japan Agency for Medical Research and Development",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Sci Rep",
    "NlmUniqueID": "101563288",
    "ISSNLinking": "2045-2322"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Chemokines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cytokines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "mortality",
        "pathology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Chemokines"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Cytokines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Models, Animal"
    },
    {
      "QualifierName": [
        "pathology",
        "virology"
      ],
      "DescriptorName": "Lung"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Inbred BALB C"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Inbred C57BL"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Principal Component Analysis"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [
        "genetics",
        "isolation & purification",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Severity of Illness Index"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Load"
    }
  ],
  "CoiStatement": "The authors declare no competing interests."
}